ADVANCED ACRAL MELANOMA

Clinical trials for ADVANCED ACRAL MELANOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED ACRAL MELANOMA trials appear

Sign up with your email to follow new studies for ADVANCED ACRAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a morning shot fight cancer better?

Disease control Recruiting now

This study is testing whether giving two immunotherapy drugs (ipilimumab and nivolumab) at specific times of day improves how well they work for advanced melanoma. Researchers want to see if receiving treatment in the morning, afternoon, or late afternoon leads to better survival…

Matched conditions: ADVANCED ACRAL MELANOMA

Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ADVANCED ACRAL MELANOMA

Get alerted when new ADVANCED ACRAL MELANOMA trials appear

Could a morning shot fight cancer better?